These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 21844082

  • 1. n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study.
    Nodari S, Triggiani M, Campia U, Manerba A, Milesi G, Cesana BM, Gheorghiade M, Dei Cas L.
    Circulation; 2011 Sep 06; 124(10):1100-6. PubMed ID: 21844082
    [Abstract] [Full Text] [Related]

  • 2. n-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study.
    Bianconi L, Calò L, Mennuni M, Santini L, Morosetti P, Azzolini P, Barbato G, Biscione F, Romano P, Santini M.
    Europace; 2011 Feb 06; 13(2):174-81. PubMed ID: 21059740
    [Abstract] [Full Text] [Related]

  • 3. N-3 polyunsaturated fatty acids administration does not reduce the recurrence rates of atrial fibrillation and inflammation after electrical cardioversion: a prospective randomized study.
    Ozaydın M, Erdoğan D, Tayyar S, Uysal BA, Doğan A, Içli A, Ozkan E, Varol E, Türker Y, Arslan A.
    Anadolu Kardiyol Derg; 2011 Jun 06; 11(4):305-9. PubMed ID: 21543294
    [Abstract] [Full Text] [Related]

  • 4. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.
    Capucci A, Villani GQ, Aschieri D, Rosi A, Piepoli MF.
    Eur Heart J; 2000 Jan 06; 21(1):66-73. PubMed ID: 10610746
    [Abstract] [Full Text] [Related]

  • 5. A randomized, placebo-controlled study of vernakalant (oral) for the prevention of atrial fibrillation recurrence after cardioversion.
    Torp-Pedersen C, Raev DH, Dickinson G, Butterfield NN, Mangal B, Beatch GN.
    Circ Arrhythm Electrophysiol; 2011 Oct 06; 4(5):637-43. PubMed ID: 21841207
    [Abstract] [Full Text] [Related]

  • 6. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.
    Vijayalakshmi K, Whittaker VJ, Sutton A, Campbell P, Wright RA, Hall JA, Harcombe AA, Linker NJ, Stewart MJ, Davies A, de Belder MA.
    Am Heart J; 2006 Apr 06; 151(4):863.e1-6. PubMed ID: 16569550
    [Abstract] [Full Text] [Related]

  • 7. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
    Frick M, Darpö B, Ostergren J, Rosenqvist M.
    Eur Heart J; 2000 Jul 06; 21(14):1177-85. PubMed ID: 10924301
    [Abstract] [Full Text] [Related]

  • 8. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.
    Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagné P, Nattel S, Thibault B.
    N Engl J Med; 2000 Mar 30; 342(13):913-20. PubMed ID: 10738049
    [Abstract] [Full Text] [Related]

  • 9. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
    Page RL, Connolly SJ, Crijns HJ, van Eickels M, Gaudin C, Torp-Pedersen C, Hohnloser SH, ATHENA Investigators.
    Am J Cardiol; 2011 Apr 01; 107(7):1019-22. PubMed ID: 21296333
    [Abstract] [Full Text] [Related]

  • 10. Amiodarone versus sotalol for atrial fibrillation.
    Singh BN, Singh SN, Reda DJ, Tang XC, Lopez B, Harris CL, Fletcher RD, Sharma SC, Atwood JE, Jacobson AK, Lewis HD, Raisch DW, Ezekowitz MD, Sotalol Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T) Investigators.
    N Engl J Med; 2005 May 05; 352(18):1861-72. PubMed ID: 15872201
    [Abstract] [Full Text] [Related]

  • 11. [Effects of pretreatment with amiodarone infusion in patients with persistent atrial fibrillation submitted to external electrical cardioversion: a single center experience].
    Maffè S, Paffoni P, Perucca A, Dellavesa P, Parravicini U, Nicali R, Bielli M, Paino AM, Signorotti F, Franchetti Pardo N, Zenone F, Zanetta M.
    G Ital Cardiol (Rome); 2008 Jul 05; 9(7):504-8. PubMed ID: 18678217
    [Abstract] [Full Text] [Related]

  • 12. Comparative effects of carvedilol and amiodarone on conversion and recurrence rates of persistent atrial fibrillation.
    Kanoupakis EM, Manios EG, Mavrakis HE, Tzerakis PG, Mouloudi HK, Vardas PE.
    Am J Cardiol; 2004 Sep 01; 94(5):659-62. PubMed ID: 15342304
    [Abstract] [Full Text] [Related]

  • 13. Long-term omega-3 polyunsaturated fatty acid supplementation reduces the recurrence of persistent atrial fibrillation after electrical cardioversion.
    Kumar S, Sutherland F, Morton JB, Lee G, Morgan J, Wong J, Eccleston DE, Voukelatos J, Garg ML, Sparks PB.
    Heart Rhythm; 2012 Apr 01; 9(4):483-91. PubMed ID: 22120130
    [Abstract] [Full Text] [Related]

  • 14. Control of rate versus rhythm in rheumatic atrial fibrillation: a randomized study.
    Vora A, Karnad D, Goyal V, Naik A, Gupta A, Lokhandwala Y, Kulkarni H, Singh B.
    Indian Heart J; 2004 Apr 01; 56(2):110-6. PubMed ID: 15377131
    [Abstract] [Full Text] [Related]

  • 15. Long-term efficacy and safety of very-low-dose amiodarone treatment for the maintenance of sinus rhythm in patients with chronic atrial fibrillation after successful direct-current cardioversion.
    Jong GP, Chang MH, Chang TC, Chou P, Fu CY, Tien LY, Chen CY, Ma TC.
    Chin Med J (Engl); 2006 Dec 20; 119(24):2030-5. PubMed ID: 17199952
    [Abstract] [Full Text] [Related]

  • 16. Maintenance of sinus rhythm with metoprolol CR initiated before cardioversion and repeated cardioversion of atrial fibrillation: a randomized double-blind placebo-controlled study.
    Nergårdh AK, Rosenqvist M, Nordlander R, Frick M.
    Eur Heart J; 2007 Jun 20; 28(11):1351-7. PubMed ID: 17329409
    [Abstract] [Full Text] [Related]

  • 17. Statins and amiodarone improve freedom from recurrence of atrial fibrillation after successful cardioversion.
    Naji F, Suran D, Kanic V, Vokac D, Sabovic M.
    Med Sci Monit; 2009 Sep 20; 15(9):CR494-8. PubMed ID: 19721402
    [Abstract] [Full Text] [Related]

  • 18. Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study.
    Lee JK, Klein GJ, Krahn AD, Yee R, Zarnke K, Simpson C, Skanes A, Spindler B.
    Am Heart J; 2000 Dec 20; 140(6):871-7. PubMed ID: 11099990
    [Abstract] [Full Text] [Related]

  • 19. Can short-term verapamil therapy reduce the recurrence of atrial fibrillation after successful low energy intracardiac cardioversion?
    Zardo F, Antonini-Canterin F, Brieda M, Hrovatin E, Pavan D, Burelli C, Cervesato E, Nicolosi GL.
    Ital Heart J; 2001 Jul 20; 2(7):513-8. PubMed ID: 11501960
    [Abstract] [Full Text] [Related]

  • 20. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
    Joseph AP, Ward MR.
    Ann Emerg Med; 2000 Jul 20; 36(1):1-9. PubMed ID: 10874228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.